Selective Elimination of Amplified CDK4 Sequences Correlates with Spontaneous Adipocytic Differentiation in Liposarcoma

被引:28
|
作者
Helias-Rodzewicz, Zofia [1 ,2 ]
Pedeutour, Florence [3 ,4 ]
Coindre, Jean-Michel [5 ]
Terrier, Philippe [6 ]
Aurias, Alain [1 ,2 ]
机构
[1] Inst Curie Genet & Biol Canc, F-75248 Paris 05, France
[2] INSERM U830, F-75248 Paris 05, France
[3] Nice Univ Hosp, Lab Solid Tumors Genet, F-06107 Nice, France
[4] Fac Med Nice, CNRS UMR 6543, F-06107 Nice, France
[5] Inst Bergonie, Dept Pathol, F-33076 Bordeaux, France
[6] Inst Gustave Roussy, Dept Pathol, F-94805 Villejuif, France
来源
GENES CHROMOSOMES & CANCER | 2009年 / 48卷 / 11期
关键词
SOFT-TISSUE TUMORS; SUPERNUMERARY RING CHROMOSOMES; DOUBLE-MINUTE CHROMOSOMES; LIPOMATOUS TUMORS; X-CHROMOSOME; DEDIFFERENTIATED LIPOSARCOMAS; CYTOGENETIC FINDINGS; MYC GENES; C-MYC; CELLS;
D O I
10.1002/gcc.20696
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Well-differentiated and undifferentiated liposarcomas are characterized by high-level amplifications of chromosome 12 regions including the CDK4 and MDM2 genes. These amplicons are either localized, in well-differentiated liposarcoma (WDLPS), on extrachromosomal structures (ring or rod chromosomes), or integrated into chromosome arms in undifferentiated tumors. Our results reveal that extrachromosomal amplicons are unstable, and frequently lost by micronucleation. This loss correlates with hypermethylation of eliminated sequences and changes of their replication time. Treatment of cells with demethylating agents during early S-phase significantly decreases the rate of micronuclei positive for CDK4. We also demonstrate that, in our model, micronuclei are generated during anaphase as a consequence of anaphase abnormalities (chromosome lagging and anaphase bridges). Finally, a dramatic increase of adipocytic differentiation was noted in cells that have eliminated copies of CDK4 gene in micronuclei. These findings provide evidence that, in WDLPS, adipocytic differentiation could be the consequence of CDK4 loss, an event occurring rarely in undifferentiated tumors in which the amplified sequences are integrated into chromosome arms. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:943 / 952
页数:10
相关论文
共 50 条
  • [21] Pre-clinical evaluation of CDK4/6 inhibitor resistance and immunologic modification in liposarcoma
    Musi, Elgilda
    Patwardhan, Parag P.
    Ingham, Matthew
    Schwartz, Gary K.
    CANCER RESEARCH, 2020, 80 (16)
  • [22] Primary dermal pleomorphic liposarcoma: utility of adipophilin and MDM2/CDK4 immunostainings
    Ramirez-Bellver, Jose L.
    Lopez, Joaquin
    Macias, Elena
    Alegria-Landa, Victoria
    Gimeno, Ignacio
    Perez-Plaza, Alejandra
    Kutzner, Heinz
    Requena, Luis
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (03) : 283 - 288
  • [23] A phase 2 trial of the CDK4 inhibitor dalpiciclib in well-differentiated or dedifferentiated liposarcoma
    Liu, Zengjun
    Liu, Mengyao
    Xu, Jing
    Hu, Wenyu
    Zhang, Hui
    Tao, Rongjie
    Li, Xinyu
    Cha, Lichao
    Cui, Jinfang
    Zhao, Junkai
    Fu, Heng
    Fan, Chunxiang
    Tian, Lantian
    Qiu, Fabo
    Zhu, Dongyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma
    Avallone, G.
    Roccabianca, P.
    Crippa, L.
    Lepri, E.
    Brunetti, B.
    Bernardini, C.
    Forni, M.
    Olandese, A.
    Sarli, G.
    VETERINARY PATHOLOGY, 2016, 53 (04) : 773 - 780
  • [25] Discovery of PF-07220060, a potent and selective CDK4 inhibitor
    Anders, Lars
    Gallego, Gary
    CANCER RESEARCH, 2024, 84 (07)
  • [26] Novel mechanisms of acquired resistance to selective CDK4/6 inhibition
    Shapiro, Geoffrey I.
    CANCER RESEARCH, 2018, 78 (13)
  • [27] Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
    Raub, Thomas J.
    Wishart, Graham N.
    Kulanthaivel, Palaniappan
    Staton, Brian A.
    Ajamie, Rose T.
    Sawada, Geri A.
    Gelbert, Lawrence M.
    Shannon, Harlan E.
    Sanchez-Martinez, Concepcion
    De Dios, Alfonso
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (09) : 1360 - 1371
  • [28] Negative MDM2/CDK4 immunoreactivity does not fully exclude MDM2/CDK4 amplification in a subset of atypical lipomatous tumor/well differentiated liposarcoma
    Machado, Isidro
    Vargas, A. Cristina
    Maclean, Fiona
    Llombart-Bosch, Antonio
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 232
  • [29] Dedifferentiated liposarcoma and pleomorphic liposarcoma A comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration
    Marino-Enriquez, Adrian
    Hornick, Jason L.
    Dal Cin, Paola
    Cibas, Edmund S.
    Qian, Xiaohua
    CANCER CYTOPATHOLOGY, 2014, 122 (02) : 128 - 137
  • [30] High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma
    Lee, Seung Eun
    Kim, Yu Jin
    Kwon, Mi Jeong
    Choi, Dong Ill
    Lee, Jeeyun
    Cho, Junhun
    Seo, Sung Wook
    Kim, Sung Joo
    Shin, Young Kee
    Choi, Yoon-La
    HISTOLOGY AND HISTOPATHOLOGY, 2014, 29 (01) : 127 - 138